Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
NCT02911844
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Fulvestrant
Sponsor
University of Pennsylvania